Serial [18F]Fluorodeoxyglucose ([18F]FDG )PET/CT as a Biomarker of Therapeutic Response in Anti-PD1/PDL1 Therapy

Clinical trial NCT02608528 · TERMINATED

Trial details

NCT number: NCT02608528
Sponsor: Abramson Cancer Center at Penn Medicine
Status: TERMINATED
Study type: OBSERVATIONAL

Non-Small Cell Lung Cancer (NSCLC)

Start date: 2015-10-22
Primary completion: 2019-07-18
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.